Ovid Therapeutics Inc. (OVID) — Dilution Risk Analysis

Current Snapshot

Ovid Therapeutics Inc. (OVID) has a DilutionWatch score of 75/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
195,297,857 Source
Public Float
161,286,911 Source
Float as % of Outstanding
82.6%

Dilution Risk Score

Score: 75/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

2 shelf registration or ATM offering filings detected in recent history.

Recent filing forms in the source payload: XBRL 1, 424B3 1, EFFECT 1, S-3 1, 8-K 2, 4 4.

FormFiledAccession
xbrl 2026-06-30 xbrl-5450-xbrl_warrant
424B3 2026-04-27 0001193125-26-182352
EFFECT 2026-04-24 9999999995-26-001333
S-3 2026-04-21 0001193125-26-166974
8-K 2026-04-20 0001628280-26-025926
4 2026-04-09 0001886431-26-000004
4 2026-04-09 0001368324-26-000004
4 2026-04-09 0001202098-26-000004
4 2026-03-25 0001256153-26-000004
8-K 2026-03-18 0001628280-26-019045

Dilution Risk Drivers

DriverStored ValueSource
Shelf registration capacity $60,000,000 Source
ATM offering capacity remaining $60,000,000 Source
Cash runway 2 months Source
Three-year share count growth 176.31% Source

DilutionWatch Analysis

Risk Level
HIGH (Score: 75/10) Source
Cash Runway
2 months Source
ATM Offering Capacity Remaining
$60,000,000 Source
Shelf Registration Capacity
$60,000,000 Source
Share Count Growth (3-Year)
176.31% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.